Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,925,661
-$52,840,639 QoQ
Shares Held
327,901
-82.2% QoQ
Ownership
0.373%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. IDYA ranks #61 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in IDYA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,925,661 | 327,901 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $63,766,300 | 1,844,556 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $103,825,305 | 3,815,704 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $105,694,424 | 5,028,279 | Shares | Defined | 2025-08-14 | |
| 2025-06-06 | $95,882,147 | 4,412,432 | Shares | Sole | 2025-06-09 | |
| 2025-03-31 | $2,295,247 | 140,125 | Shares | Defined | 2025-07-21 | |
| 2023-03-31 | $72,288 | 5,265 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $48,713 | 2,681 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $20,824,200 | 1,509,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $20,668,120 | 1,847,017 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $31,923,456 | 1,350,400 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $25,061,768 | 983,200 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,481,945 | 689,945 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $19,591,950 | 833,700 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $15,555,554 | 1,111,111 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $14,527,699 | 1,156,664 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $14,341,641 | 1,009,264 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $814,173 | 197,615 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||